Loading clinical trials...

Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications | Clinical Trials | Clareo Health

COMPLETEDNCT04353869

Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications

Experimental data suggest that glutamine catabolism in involved in the activation of macrophages by generating TCA(Tricarboxylic acid) intermediates that promote the pro-inflammatory polarization of m...

Lead sponsor: Assistance Publique - Hôpitaux de Paris•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 3

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

NCT07231419 · Diabetic Peripheral Neuropathic Pain

RECRUITINGPhase 1

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)

NCT07425522 · Diabetic Macular Edema

RECRUITINGPhase 2

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

NCT06614322 · Painful Peripheral Neuropathy, Diabetic Peripheral Neuropathic Pain (DPN), and more

RECRUITINGPhase 2

BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers

NCT06383013 · Diabetic Foot Ulcer

RECRUITINGNA

PAW-Hydrogel for Chronic Wound Healing

NCT07541196 · Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 5, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment995

Start dateNov 2020

Last updatedMar 5, 2025

Condition

Glutamine Diabetic Cardiovascular Complications

Locations shown

Diabétologie - Hôpital Lariboisière

Paris, France

Diabetologie Bichat

Paris, France

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions